Nusano
PrivateLast Round
Series C
Oct 1, 2024
Est. Valuation
$208.31M
Total Funding Raised
$265.65M
Company Overview
Nusano is a medical technology company that develops advanced ion sources and linear accelerators to enhance radioisotope manufacturing for medical and industrial applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nusano Comparables
Compare Nusano with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NorthStar Medical Radioisotopes, LLC | 84% | |
| Niowave Inc. | 83% | |
| SHINE Technologies | 83% |
Nusano Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 1, 2024 | ||||
| Series B | Nov 1, 2022 | ||||
| Series B | Sep 8, 2021 | ||||
| Seed | Oct 24, 2018 | ||||
| Seed | Oct 23, 2017 |
Key People
Founding team and executive leadership
Nusano Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series C |
| BrightEdge | Series C, Series B |
| Wasatch Equity Partners | Series B, Series C |
| BrightEdge | Series B |
| Wasatch Venture Partners | Series C |
| Casdin Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 11, 2025
Received 'Best Companies to Work For' Award from Utah Business.
- Nov 12, 2025
Team members attended the Utah Life Sciences Summit on November 12, 2025.
Recent news
Latest coverage and updates
- signs_new_clientSep 15, 2026
Nusano signed new client DOE on Sep 14th '26.
Nusano Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nusano's valuation, stock price, and market status.
Is Nusano a public or private company?
Nusano is a private company.
What is the current stock price of Nusano?
Nusano is a private company, so its shares have no public market price. Caplight tracks Nusano's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nusano worth (valuation)?
Nusano's valuation is estimated at $208.3M based on funding round data.
Can I buy Nusano stock?
Nusano shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nusano's last funding round?
Nusano's most recent funding round was Series C on October 1, 2024.
Who are the main investors in Nusano?
Key investors in Nusano include Wasatch Equity Partners, Wasatch Venture Partners.
Will Nusano IPO soon?
No public IPO plans have been announced for Nusano.
How can I track Nusano secondary market activity?
Caplight tracks bids, offers, and trades in Nusano's shares on secondary markets.